Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,067 | -15,190 | -21,651 | -12,056 | -4,340 |
| Accounts payable and accrued liabilities | 775 | 599 | -993 | -687 | 1,341 |
| Other Working Capital | -4,780 | 4,791 | 3,059 | -3,399 | 1,328 |
| Other Operating Activity | -641 | -55 | 1,738 | 1,599 | 286 |
| Operating Cash Flow | $-16,713 | $-9,854 | $-17,847 | $-14,543 | $-1,385 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 100 | 72 |
| Debt Repayment | N/A | N/A | N/A | -1,604 | 0 |
| Common Stock Issued | 9,084 | N/A | N/A | 58,020 | 1,377 |
| Other Financing Activity | 0 | 0 | 0 | -5,186 | -51 |
| Financing Cash Flow | $9,084 | $N/A | $N/A | $51,330 | $1,398 |
| Beginning Cash Position | 9,142 | 18,995 | 36,842 | 55 | 42 |
| End Cash Position | 1,513 | 9,142 | 18,995 | 36,842 | 55 |
| Net Cash Flow | $-7,629 | $-9,854 | $-17,847 | $36,787 | $13 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,713 | -9,854 | -17,847 | -14,543 | -1,385 |
| Free Cash Flow | -16,713 | -9,854 | -17,847 | -14,543 | -1,385 |